Informations:
Erreur:
ID
31043
Description
Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00457119
Lien
https://clinicaltrials.gov/show/NCT00457119
Mots-clés
Versions (1)
- 12/07/2018 12/07/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
12 juillet 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Non Small Cell Lung Cancer NCT00457119
Eligibility Non Small Cell Lung Cancer NCT00457119
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Cancer NCT00457119
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
age over 18 years
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging
Item
advanced non small cell lung cancer (stage iiib/iv)
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Ability Performance of activities of daily living
Item
ability to perform normal daily functions
boolean
C0085732 (UMLS CUI [1,1])
C1821398 (UMLS CUI [1,2])
C1821398 (UMLS CUI [1,2])
Steroid therapy chronic
Item
chronic steroid treatment
boolean
C0149783 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,2])
Prior Chemotherapy Advanced lung cancer
Item
prior treatment with chemotherapy for advanced lung cancer
boolean
C1514457 (UMLS CUI [1,1])
C4524268 (UMLS CUI [1,2])
C4524268 (UMLS CUI [1,2])
mTOR Inhibitors
Item
prior treatment with mtor inhibitors
boolean
C1515672 (UMLS CUI [1])
Blood Coagulation Disorders | Dermatologic disorders | Gastrointestinal Diseases | Oral Ulcer | Disorder of eye | Chronic liver disease | Chronic Kidney Diseases | Diabetic - poor control | Communicable Diseases | Other medical condition Severe
Item
active bleeding conditions, skin conditions, gastrointestinal disorders, mouth ulcers, eye conditions, chronic liver or kidney disorders, uncontrolled diabetes, infections or other severe medical conditions
boolean
C0005779 (UMLS CUI [1])
C0037274 (UMLS CUI [2])
C0017178 (UMLS CUI [3])
C0149745 (UMLS CUI [4])
C0015397 (UMLS CUI [5])
C0341439 (UMLS CUI [6])
C1561643 (UMLS CUI [7])
C0421258 (UMLS CUI [8])
C0009450 (UMLS CUI [9])
C3843040 (UMLS CUI [10,1])
C0205082 (UMLS CUI [10,2])
C0037274 (UMLS CUI [2])
C0017178 (UMLS CUI [3])
C0149745 (UMLS CUI [4])
C0015397 (UMLS CUI [5])
C0341439 (UMLS CUI [6])
C1561643 (UMLS CUI [7])
C0421258 (UMLS CUI [8])
C0009450 (UMLS CUI [9])
C3843040 (UMLS CUI [10,1])
C0205082 (UMLS CUI [10,2])
Hypersensitivity Platinum Compounds | Hypersensitivity Taxanes | Hypersensitivity Bevacizumab
Item
known sensitivity to platinum compounds, taxanes or bevacizumab
boolean
C0020517 (UMLS CUI [1,1])
C3536919 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0796419 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0796392 (UMLS CUI [3,2])
C3536919 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0796419 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0796392 (UMLS CUI [3,2])
Cancer Other
Item
other cancers within the past 5 years
boolean
C1707251 (UMLS CUI [1])
Pregnancy | Breast Feeding | Eligibility Criteria Study Protocol
Item
pregnant or breastfeeding women other protocol-defined inclusion/exclusion criteria may apply
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C1516637 (UMLS CUI [3,1])
C2348563 (UMLS CUI [3,2])
C0006147 (UMLS CUI [2])
C1516637 (UMLS CUI [3,1])
C2348563 (UMLS CUI [3,2])